XML 53 R45.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting - Schedule of Segment Loss Including Significant Segment Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting [Abstract]    
Navacaprant (NMRA-140) program $ (24,493) $ (24,319)
M4 PAM programs (2,882) (3,524)
NMRA-511 program (2,580) (1,887)
Preclinical programs (1,002) (2,409)
Research and development personnel-related costs (12,326) (10,875)
General and administrative expense (18,785) (14,317)
Interest income 3,074 6,365
Other segment items (8,998) (2,755)
Net loss $ (67,992) $ (53,721)